{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:54:36Z","timestamp":1787003676051,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangsu Province Traditional Chinese Medicine Technology Development Plan Project","award":["MS2023151"],"award-info":[{"award-number":["MS2023151"]}]},{"name":"Taizhou Clinical Medical College of Nanjing Medical University","award":["TZKY20230302"],"award-info":[{"award-number":["TZKY20230302"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170153"],"award-info":[{"award-number":["82170153"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-95607-5","type":"journal-article","created":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T08:19:32Z","timestamp":1745137172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Disulfidptosis-related LncRNAs forecast the prognosis of acute myeloid leukemia"],"prefix":"10.1038","volume":"15","author":[{"given":"Pei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxiao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixuan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,20]]},"reference":[{"key":"95607_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","volume":"11","author":"H Kantarjian","year":"2021","unstructured":"Kantarjian, H. et al. Acute myeloid leukemia: current progress and future directions. Blood Cancer J. 11, 41 (2021).","journal-title":"Blood Cancer J."},{"key":"95607_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","volume":"29","author":"D Tang","year":"2019","unstructured":"Tang, D., Kang, R., Berghe, T. V., Vandenabeele, P. & Kroemer, G. The molecular machinery of regulated cell death. Cell. Res. 29, 347\u2013364 (2019).","journal-title":"Cell. Res."},{"key":"95607_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","volume":"25","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Actin cytoskeleton vulnerability to disulfide stress mediates Disulfidptosis. Nat. Cell. Biol. 25, 404\u2013414 (2023).","journal-title":"Nat. Cell. Biol."},{"key":"95607_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13046-023-02675-4","volume":"42","author":"P Zheng","year":"2023","unstructured":"Zheng, P., Zhou, C., Ding, Y. & Duan, S. Disulfidptosis: a new target for metabolic cancer therapy. J. Exp. Clin. Cancer Res. 42, 103 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"95607_CR5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.ccell.2018.08.016","volume":"34","author":"H Ye","year":"2018","unstructured":"Ye, H. et al. Subversion of systemic glucose metabolism as a mechanism to support the growth of leukemia cells. Cancer Cell. 34, 659\u2013673e6 (2018).","journal-title":"Cancer Cell."},{"key":"95607_CR6","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1038\/s41375-022-01573-6","volume":"36","author":"B Pardieu","year":"2022","unstructured":"Pardieu, B. et al. Cystine uptake Inhibition potentiates front-line therapies in acute myeloid leukemia. Leukemia 36, 1585\u20131595 (2022).","journal-title":"Leukemia"},{"key":"95607_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41556-023-01100-4","volume":"25","author":"LM Machesky","year":"2023","unstructured":"Machesky, L. M. Deadly actin collapse by Disulfidptosis. Nat. Cell. Biol. 25, 375\u2013376 (2023).","journal-title":"Nat. Cell. Biol."},{"key":"95607_CR8","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nm.3981","volume":"21","author":"M Huarte","year":"2015","unstructured":"Huarte, M. The emerging role of LncRNAs in cancer. Nat. Med. 21, 1253\u20131261 (2015).","journal-title":"Nat. Med."},{"key":"95607_CR9","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.3390\/pharmaceutics13101681","volume":"13","author":"P Connerty","year":"2021","unstructured":"Connerty, P. et al. Development of siRNA-Loaded lipid nanoparticles targeting long Non-Coding RNA LINC01257 as a novel and safe therapeutic approach for t(8;21) pediatric acute myeloid leukemia. Pharmaceutics 13, 1681 (2021).","journal-title":"Pharmaceutics"},{"key":"95607_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/MOH.0000000000000692","volume":"29","author":"S Mishra","year":"2022","unstructured":"Mishra, S., Liu, J., Chai, L. & Tenen, D. G. Diverse functions of long noncoding RNAs in acute myeloid leukemia: emerging roles in pathophysiology, prognosis, and treatment resistance. Curr. Opin. Hematol. 29, 34\u201343 (2022).","journal-title":"Curr. Opin. Hematol."},{"key":"95607_CR11","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1038\/s41467-021-22095-2","volume":"12","author":"G Zhu","year":"2021","unstructured":"Zhu, G. et al. HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia. Nat. Commun. 12, 1956 (2021).","journal-title":"Nat. Commun."},{"key":"95607_CR12","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.1182\/bloodadvances.2019032029","volume":"3","author":"S Al-Kershi","year":"2019","unstructured":"Al-Kershi, S. et al. The stem cell-specific long noncoding RNA HOXA10-AS in the pathogenesis of KMT2A-rearranged leukemia. Blood Adv. 3, 4252\u20134263 (2019).","journal-title":"Blood Adv."},{"key":"95607_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ccell.2019.10.011","volume":"36","author":"H Luo","year":"2019","unstructured":"Luo, H. et al. HOTTIP LncRNA promotes hematopoietic stem cell Self-Renewal leading to AML-like disease in mice. Cancer Cell. 36, 645\u2013659e8 (2019).","journal-title":"Cancer Cell."},{"key":"95607_CR14","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1001\/jamaoncol.2016.0097","volume":"2","author":"J McKiernan","year":"2016","unstructured":"McKiernan, J. et al. A novel urine exosome gene expression assay to predict High-grade prostate cancer at initial biopsy. JAMA Oncol. 2, 882\u2013889 (2016).","journal-title":"JAMA Oncol."},{"key":"95607_CR15","doi-asserted-by":"publisher","first-page":"1254232","DOI":"10.3389\/fmolb.2023.1254232","volume":"10","author":"H Chi","year":"2023","unstructured":"Chi, H. et al. Unraveling the role of disulfidptosis-related LncRNAs in colon cancer: a prognostic indicator for immunotherapy response, chemotherapy sensitivity, and insights into cell death mechanisms. Front. Mol. Biosci. 10, 1254232 (2023).","journal-title":"Front. Mol. Biosci."},{"key":"95607_CR16","doi-asserted-by":"crossref","unstructured":"F, Z. et al. m6A-related LncRNAs predict prognosis and indicate immune microenvironment in acute myeloid leukemia. Sci. Rep. 12, (2022).","DOI":"10.1038\/s41598-022-05797-5"},{"key":"95607_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13045-018-0596-2","volume":"11","author":"AS Mer","year":"2018","unstructured":"Mer, A. S. et al. Expression levels of long non-coding RNAs are prognostic for AML outcome. J. Hematol. Oncol. 11, 52 (2018).","journal-title":"J. Hematol. Oncol."},{"key":"95607_CR18","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.1007\/s00277-024-05987-3","volume":"103","author":"A Atnaf","year":"2024","unstructured":"Atnaf, A. et al. The role of long noncoding RNAs in the diagnosis, prognosis and therapeutic biomarkers of acute myeloid leukemia. Ann. Hematol. 103, 4931\u20134942 (2024).","journal-title":"Ann. Hematol."},{"key":"95607_CR19","doi-asserted-by":"publisher","first-page":"966920","DOI":"10.3389\/fonc.2022.966920","volume":"12","author":"P Li","year":"2022","unstructured":"Li, P. et al. A novel cuproptosis-related LncRNA signature: prognostic and therapeutic value for acute myeloid leukemia. Front. Oncol. 12, 966920 (2022).","journal-title":"Front. Oncol."},{"key":"95607_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401\u2013404 (2012).","journal-title":"Cancer Discov"},{"key":"95607_CR21","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).","journal-title":"Sci. Signal."},{"key":"95607_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"95607_CR23","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013462 (2016).","journal-title":"Nucleic Acids Res."},{"key":"95607_CR24","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.exphem.2016.04.012","volume":"44","author":"U Testa","year":"2016","unstructured":"Testa, U., Labbaye, C., Castelli, G. & Pelosi, E. Oxidative stress and hypoxia in normal and leukemic stem cells. Exp. Hematol. 44, 540\u2013560 (2016).","journal-title":"Exp. Hematol."},{"key":"95607_CR25","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1182\/blood-2014-08-594408","volume":"125","author":"S Sriskanthadevan","year":"2015","unstructured":"Sriskanthadevan, S. et al. AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress. Blood 125, 2120\u20132130 (2015).","journal-title":"Blood"},{"key":"95607_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40170-021-00253-w","volume":"9","author":"SB Panina","year":"2021","unstructured":"Panina, S. B., Pei, J. & Kirienko, N. V. Mitochondrial metabolism as a target for acute myeloid leukemia treatment. Cancer Metab. 9, 17 (2021).","journal-title":"Cancer Metab."},{"key":"95607_CR27","doi-asserted-by":"publisher","first-page":"20135","DOI":"10.1038\/s41598-023-47472-3","volume":"13","author":"L Xiao","year":"2023","unstructured":"Xiao, L. et al. A disulfidptosis-related LncRNA index predicting prognosis and the tumor microenvironment in colorectal cancer. Sci. Rep. 13, 20135 (2023).","journal-title":"Sci. Rep."},{"key":"95607_CR28","doi-asserted-by":"publisher","first-page":"129584","DOI":"10.1016\/j.ijbiomac.2024.129584","volume":"261","author":"J Qu","year":"2024","unstructured":"Qu, J., Guan, H., Zheng, Q. & Sun, F. Molecular subtypes of disulfidptosis-regulated genes and prognosis models for predicting prognosis, tumor microenvironment infiltration, and therapeutic response in hepatocellular carcinoma. Int. J. Biol. Macromol. 261, 129584 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"95607_CR29","doi-asserted-by":"publisher","first-page":"1198826","DOI":"10.3389\/fimmu.2023.1198826","volume":"14","author":"J Liang","year":"2023","unstructured":"Liang, J. et al. Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer. Front. Immunol. 14, 1198826 (2023).","journal-title":"Front. Immunol."},{"key":"95607_CR30","doi-asserted-by":"publisher","first-page":"1272701","DOI":"10.3389\/fphar.2023.1272701","volume":"14","author":"F Zhong","year":"2023","unstructured":"Zhong, F. et al. Development and validation of a disulfidptosis-related scoring system to predict clinical outcome and immunotherapy response in acute myeloid leukemia by integrated analysis of single-cell and bulk RNA-sequencing. Front. Pharmacol. 14, 1272701 (2023).","journal-title":"Front. Pharmacol."},{"key":"95607_CR31","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.21037\/tcr-22-2526","volume":"12","author":"T Zhang","year":"2023","unstructured":"Zhang, T., Liao, D. & Hu, Y. Cuproptosis-related LncRNAs forecast the prognosis of acute myeloid leukemia. Transl Cancer Res. 12, 1175\u20131195 (2023).","journal-title":"Transl Cancer Res."},{"key":"95607_CR32","first-page":"1473","volume":"18","author":"F Wang","year":"2018","unstructured":"Wang, F. et al. A three\u2013lncRNA signature for prognosis prediction of acute myeloid leukemia in patients. Mol. Med. Rep. 18, 1473\u20131484 (2018).","journal-title":"Mol. Med. Rep."},{"key":"95607_CR33","doi-asserted-by":"publisher","first-page":"11293","DOI":"10.1038\/s41598-018-29593-2","volume":"8","author":"R Hornung","year":"2018","unstructured":"Hornung, R. et al. Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1\/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia. Sci. Rep. 8, 11293 (2018).","journal-title":"Sci. Rep."},{"key":"95607_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ijcard.2022.08.035","volume":"369","author":"A Zietzer","year":"2022","unstructured":"Zietzer, A. et al. The LncRNA MRPL20-AS1 is associated with severe OSAS and downregulated upon hypoxic injury of endothelial cells. Int. J. Cardiol. 369, 65\u201368 (2022).","journal-title":"Int. J. Cardiol."},{"key":"95607_CR35","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3390\/biomedicines12030544","volume":"12","author":"PV Ershov","year":"2024","unstructured":"Ershov, P. V., Yablokov, E. O., Mezentsev, Y. V. & Ivanov, A. S. Long intergenic Non-Coding RNAs of human chromosome 18: focus on cancers. Biomedicines 12, 544 (2024).","journal-title":"Biomedicines"},{"key":"95607_CR36","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.2147\/IJGM.S460164","volume":"17","author":"Y Hong","year":"2024","unstructured":"Hong, Y. et al. Ferroptosis-Related gene signature for prognosis prediction in acute myeloid leukemia and potential therapeutic options. Int. J. Gen. Med. 17, 3837\u20133853 (2024).","journal-title":"Int. J. Gen. Med."},{"key":"95607_CR37","doi-asserted-by":"publisher","first-page":"770451","DOI":"10.3389\/fcell.2021.770451","volume":"9","author":"D Li","year":"2021","unstructured":"Li, D. et al. Identification of m6A-Related LncRNAs associated with prognoses and immune responses in acute myeloid leukemia. Front. Cell. Dev. Biol. 9, 770451 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"95607_CR38","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.gendis.2020.11.010","volume":"8","author":"X Liu","year":"2021","unstructured":"Liu, X., Zhang, Y., Zhuang, L., Olszewski, K. & Gan, B. NADPH debt drives redox bankruptcy: SLC7A11\/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation. Genes Dis. 8, 731\u2013745 (2021).","journal-title":"Genes Dis."},{"key":"95607_CR39","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12916-021-02047-9","volume":"19","author":"T Zeng","year":"2021","unstructured":"Zeng, T. et al. The establishment of a prognostic scoring model based on the new tumor immune microenvironment classification in acute myeloid leukemia. BMC Med. 19, 176 (2021).","journal-title":"BMC Med."},{"key":"95607_CR40","doi-asserted-by":"publisher","first-page":"811144","DOI":"10.3389\/fimmu.2022.811144","volume":"13","author":"T Menter","year":"2022","unstructured":"Menter, T. & Tzankov, A. Tumor microenvironment in acute myeloid leukemia: adjusting niches. Front. Immunol. 13, 811144 (2022).","journal-title":"Front. Immunol."},{"key":"95607_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fonc.2018.00213","volume":"8","author":"AJ Lamble","year":"2018","unstructured":"Lamble, A. J. & Lind, E. F. Targeting the immune microenvironment in acute myeloid leukemia: A focus on T cell immunity. Front. Oncol. 8, 213 (2018).","journal-title":"Front. Oncol."},{"key":"95607_CR42","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1182\/blood-2011-11-394395","volume":"120","author":"J Greiner","year":"2012","unstructured":"Greiner, J. et al. Mutated regions of nucleophosmin 1 elicit both CD4(+) and CD8(+) T-cell responses in patients with acute myeloid leukemia. Blood 120, 1282\u20131289 (2012).","journal-title":"Blood"},{"key":"95607_CR43","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12964-023-01282-2","volume":"21","author":"M Bakhtiyari","year":"2023","unstructured":"Bakhtiyari, M. et al. The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways. Cell. Commun. Signal. 21, 252 (2023).","journal-title":"Cell. Commun. Signal."},{"key":"95607_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000500588","volume":"143","author":"Z Guo","year":"2020","unstructured":"Guo, Z. et al. The association of Circulating T follicular helper cells and regulatory cells with acute myeloid leukemia patients. Acta Haematol. 143, 19\u201325 (2020).","journal-title":"Acta Haematol."},{"key":"95607_CR45","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.drudis.2019.11.003","volume":"25","author":"S Singh","year":"2020","unstructured":"Singh, S. et al. Immune checkpoint inhibitors: a promising anticancer therapy. Drug Discov Today. 25, 223\u2013229 (2020).","journal-title":"Drug Discov Today"},{"key":"95607_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40164-022-00263-4","volume":"11","author":"X Yang","year":"2022","unstructured":"Yang, X., Ma, L., Zhang, X., Huang, L. & Wei, J. Targeting PD-1\/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia. Exp. Hematol. Oncol. 11, 11 (2022).","journal-title":"Exp. Hematol. Oncol."},{"key":"95607_CR47","doi-asserted-by":"publisher","first-page":"E4223","DOI":"10.1073\/pnas.1617941114","volume":"114","author":"UA Ramagopal","year":"2017","unstructured":"Ramagopal, U. A. et al. Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab. Proc. Natl. Acad. Sci. U S A. 114, E4223\u2013E4232 (2017).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"95607_CR48","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa2109970","volume":"386","author":"HA Tawbi","year":"2022","unstructured":"Tawbi, H. A. et al. Relatlimab and nivolumab versus nivolumab in untreated advanced melanoma. N Engl. J. Med. 386, 24\u201334 (2022).","journal-title":"N Engl. J. Med."},{"key":"95607_CR49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cancergen.2023.10.001","volume":"278\u2013279","author":"H Liu","year":"2023","unstructured":"Liu, H. & Tang, T. Pan-cancer genetic analysis of disulfidptosis-related gene set. Cancer Genet. 278\u2013279, 91\u2013103 (2023).","journal-title":"Cancer Genet."},{"key":"95607_CR50","doi-asserted-by":"publisher","first-page":"110368","DOI":"10.1016\/j.intimp.2023.110368","volume":"120","author":"T Wang","year":"2023","unstructured":"Wang, T. et al. Disulfidptosis classification of hepatocellular carcinoma reveals correlation with clinical prognosis and immune profile. Int. Immunopharmacol. 120, 110368 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"95607_CR51","doi-asserted-by":"publisher","first-page":"1372330","DOI":"10.3389\/fcell.2024.1372330","volume":"12","author":"H Su","year":"2024","unstructured":"Su, H., Peng, C. & Liu, Y. Regulation of ferroptosis by PI3K\/Akt signaling pathway: a promising therapeutic axis in cancer. Front. Cell. Dev. Biol. 12, 1372330 (2024).","journal-title":"Front. Cell. Dev. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95607-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95607-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95607-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T10:01:28Z","timestamp":1745143288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95607-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,20]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["95607"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-95607-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,20]]},"assertion":[{"value":"24 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13635"}}